Top Updates Back
Astellas Pharma Australia Pty Ltd.
製品の販売
研究開発
デジタルヘルスソリューション
サステナビリティ活動
Pharmaceutical development and manufacturing
Research and development of medicines
Digital health solutions
製品
パイプライン
Rx+事業創成
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Avara Norman Pharmaceutical Services, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Nippon Medical & Pharmaceutical Co., Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Takeda Pharmaceutical Company Limited
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Takeda Teba Pharma Co., Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Takeda Teba Pharmaceutical Co., Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

2 entries
DateDescription
2005-04 Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy.
2025-04 In April 2025, Astellas celebrated our 20th Anniversary as a company.
+ Loaded when opened
✅
2026-09-21 18:04 (Model: ggml-org/gpt-oss-20b )
↑